Guardian Pharmacy Services, INC Form 4 insider transactions
NYSE
Cardinal Equity Fund, a 10% owner, sold 275,728 shares of Guardian Pharmacy Services Class A Common Stock for approximately $8.19 million.
NYSE
A director and 10% owner of Guardian Pharmacy Services, Inc. sold over 3.6 million shares of Class A Common Stock for approximately $107 million.
NYSE
Bindley Capital Partners I, LLC, a 10% owner and director of Guardian Pharmacy Services, Inc., reported the sale of 3,570,677 shares of Class A common stock for approximately $106 million.
NYSE
John Ackerman, a Director and 10% owner of Guardian Pharmacy Services, Inc., sold over 1.1 million shares of Class A Common Stock at $29.6825 per share through an underwritten agreement.
NYSE
Guardian Pharmacy Services Director and 10% owner William E. Bindley sold over 3.5 million shares of Class A Common Stock for approximately $106 million.
NYSE
Fred Burke, CEO of Guardian Pharmacy Services, gifted 200,000 shares of Class A Common Stock to a charitable donor-advised fund.
NYSE
Kendall Forbes, Executive Vice President of Guardian Pharmacy Services, gifted 21,500 shares of Class A Common Stock to a charitable donor-advised fund.
NYSE
A director at Guardian Pharmacy Services, Steven D. Cosler, purchased 3,370 shares of Class A Common Stock for approximately $99,889.70.
NYSE
Director John Ackerman reported the automatic conversion of Class B to Class A common stock for Guardian Pharmacy Services, Inc. through indirect holdings.
NYSE
Kendall Forbes, Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc., reported the first of three automatic conversions of 608,570 Class B common shares into Class A common shares.
NYSE
Cardinal Equity Fund, a member of a 10% owner group, reported sales of Guardian Pharmacy Services Class A common stock and an automatic conversion of Class B to Class A shares.
NYSE
Bindley Capital Partners I, LLC, a 10% owner and director, reported the automatic conversion of 6,100,176 Class B common shares into Class A common shares of Guardian Pharmacy Services, Inc.
NYSE
Thomas J. Salentine Jr., a Director and 10% owner of Guardian Pharmacy Services, Inc., reported the automatic conversion of over 6 million Class B common shares into Class A common shares.
NYSE
Guardian Pharmacy Services CFO David K. Morris converted Class B shares to Class A and disclosed future share transfers related to a divorce settlement.
NYSE
William E. Bindley, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported the future automatic conversion of 6,100,176 Class B common shares into Class A common shares, scheduled for September 27, 2025.
NYSE
Pharmacy Investors, LLC, a 10% owner of Guardian Pharmacy Services, Inc., reported sales of Class A common stock and the automatic conversion of Class B shares into Class A shares.
NYSE
Fred Burke, CEO of Guardian Pharmacy Services, converted 1.3 million Class B shares into Class A common stock as part of a pre-scheduled plan.
NYSE
Kendall Forbes, Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc., reported the sale of 415,049 shares of Class A Common Stock for approximately $8.37 million through pre-arranged transactions.
NYSE
William E. Bindley, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported the sale of over 4 million shares of Class A Common Stock for approximately $20.16 per share across two transactions.
NYSE
A director and 10% owner of Guardian Pharmacy Services, Inc., Thomas J. Salentine Jr., through Bindley Capital Partners I, LLC, sold over 4.1 million shares of Class A Common Stock for approximately $84 million.
NYSE
John Ackerman, a Director and 10% owner of Guardian Pharmacy Services, Inc., sold a total of 1,284,579 shares of Class A Common Stock for $20.16 per share through an underwriting agreement.
NYSE
Fred Burke, President and CEO of Guardian Pharmacy Services, Inc., has reported the sale of 885,807 shares of Class A Common Stock for approximately $17.85 million, as part of a pre-arranged underwriting agreement.
NYSE
David K. Morris, Executive Vice President and Chief Financial Officer of Guardian Pharmacy Services, Inc., sold 437,759 shares of Class A Common Stock for approximately $8.8 million through pre-arranged Rule 10b5-1 plans.
NYSE
Form 4: Major Shareholder Bindley Capital Sells Over $83 Million in Guardian Pharmacy Services Stock
Bindley Capital Partners I, LLC, a 10% owner and director of Guardian Pharmacy Services, Inc., has sold over 4.1 million shares of Class A Common Stock for approximately $83.88 million.
NYSE
Director Steven D. Cosler reports acquisition of Guardian Pharmacy Services Class A Common Stock.
NYSE
Mary Sue Patchett, a director at Guardian Pharmacy Services, acquired 3,901 shares of Class A Common Stock through restricted stock units on May 9, 2025.
NYSE
Director Randall J Lewis reports acquisition of Guardian Pharmacy Services Class A Common Stock.
NYSE
Thomas J. Salentine Jr., a director at Guardian Pharmacy Services, converted a portion of his Class B common stock into Class A common stock on March 28, 2025.
NYSE
Director Fred Burke converts 1,298,826 shares of Class B common stock to Class A common stock in Guardian Pharmacy Services, Inc.
NYSE
William E. Bindley, a director and 10% owner of Guardian Pharmacy Services, converted 6,100,176 shares of Class B common stock into Class A common stock on March 28, 2025.